Core Insights - Healthcare stocks in the S&P 500 provide an average dividend yield of 1.8%, making them a reliable source of income even during market downturns [1][3]. Healthcare Sector Overview - The healthcare sector is characterized by its ability to offer dividends, unlike tech stocks that typically reinvest profits [2]. - Companies in this sector are seen as more stable and reliable for dividend income [2]. AbbVie - AbbVie, a major pharmaceutical company, has a market capitalization of $385 billion and reported $59 billion in revenue over the last 12 months [4]. - The company’s third-quarter revenue was $15.8 billion, a 9.1% increase year-over-year, driven by strong sales of Skyrizi and Rinvoq, despite a significant drop in Humira revenue [6]. - AbbVie’s stock has increased by 20% this year, and it offers a dividend yield of 3.1%, with a recent dividend increase of 5.5% [7]. UnitedHealth Group - UnitedHealth Group's stock has decreased by 34% this year, primarily due to unmet expectations and misjudged medical claims [8][9]. - The company reported third-quarter revenue of $113.2 billion, a 12% increase from the previous year, and has a dividend yield of 2.6% [11]. - UnitedHealth is making adjustments to its Medicare Advantage benefits and pricing to improve margins in the coming years [10]. CVS Health - CVS Health has diversified its operations post-Aetna acquisition, engaging in retail, insurance, and primary care [13]. - The company reported third-quarter revenue of $102.8 billion, a 7.8% increase year-over-year, with adjusted operating income up 35% [14]. - CVS stock has surged by 74% this year, and it offers a dividend yield of 3.4%, indicating strong momentum [16].

Core Insights - The "High Income DIY Portfolios" service aims to provide high income with low risk and capital preservation for DIY investors, particularly targeting income investors such as retirees [1] - The service offers a total of ten model portfolios, including three buy-and-hold portfolios, three rotational portfolios, and a conservative NPP strategy portfolio, designed to create stable, long-term passive income with sustainable yields [2] Portfolio Details - The portfolios include two high-income portfolios, two dividend growth investing (DGI) portfolios, and a conservative NPP strategy portfolio that focuses on low drawdowns and high growth [1] - The investment approach emphasizes a unique 3-basket strategy that targets 30% lower drawdowns and aims for a 6% current income with market-beating growth over the long term [2] Additional Features - The service provides buy and sell alerts, live chat, and strategies for portfolio management and asset allocation to enhance income generation [2]

Core Viewpoint - The article highlights three undervalued stocks—AbbVie, Lockheed Martin, and PayPal—that offer growth potential and dividends, making them attractive investment options for long-term investors [2]. AbbVie - AbbVie is considered a strong investment due to its low valuation and significant growth opportunities, with a forward P/E ratio of just under 17 despite a trailing P/E over 100 [3][4]. - The company reported an 8% increase in revenue for the first nine months of the year, reaching $44.5 billion, with immunology drugs contributing nearly $22 billion and growing over 12% [4]. - AbbVie offers a dividend yield of 3.3%, enhancing the investment's value, and the stock has appreciated by 19% this year [6]. Lockheed Martin - Lockheed Martin is another appealing stock, trading at a forward P/E of 17, positioned to benefit from increased government spending on defense and aerospace [7][11]. - The company generated $54.7 billion in sales in the first nine months of 2025, reflecting a modest 4% year-over-year growth [11]. - Lockheed Martin provides a dividend yield of 2.8%, which is significantly higher than the S&P 500 average of 1.1% [11]. PayPal - PayPal is identified as the cheapest stock on the list, with a forward P/E of only 12 and a PEG ratio of less than 1, indicating strong long-term value [12]. - The company experienced a nearly 5% increase in net revenue to $24.5 billion and a 25% rise in net income to $3.8 billion during the first nine months of the year [15]. - PayPal has recently started paying a dividend, albeit with a low yield of 0.8%, which could contribute to overall returns [16].

Core Viewpoint - The company emphasizes providing actionable and clear investment ideas through independent research, aiming to help members outperform the S&P 500 and mitigate significant losses during market volatility [1] Group 1 - The investment style promoted by the company focuses on delivering in-depth articles on actionable investment ideas at least once a week [1] - The company claims to have assisted its members in not only beating the S&P 500 but also in avoiding substantial drawdowns amid extreme volatility in both equity and bond markets [1]

AbbVie Inc. (NYSE:ABBV) is included among the 15 Best DRIP Stocks to Own Right Now. Piper Sandler Raises AbbVie (ABBV) Price Target to $289, Maintains Overweight Rating Photo by Dan Dennis on Unsplash On November 5, Piper San‍dler​ analyst David Amsellem raised the price target on AbbVie Inc. (NYSE:ABBV) from⁠ $284 to $289 while maintaining an Over‌weight rating on the stock foll‌owing its quarte‍rly re​sults, as reported by The Fly. The analyst att‍ributed the increase to s‌tronger long-term expectatio ...

Key TakeawaysU.S. Michigan Consumer Sentiment sharply declined in November to 50.3, significantly missing both previous readings and analyst expectations, signaling growing consumer pessimism.Short-term inflation expectations for the next year edged higher to 4.7%, while longer-term 5-year inflation expectations eased slightly to 3.6%.Major U.S. stock indices, including the Nasdaq, Dow Jones, and S&P 500, opened lower following the release of the disappointing consumer data.UBS raised its price target for p ...

AbbVie’s third quarter results were marked by strong year-on-year revenue growth, driven primarily by continued momentum in its immunology and neuroscience portfolios. Management pointed to sales growth from Skyrizi and Rinvoq, as well as double-digit expansion in neuroscience products, as key contributors to the performance. However, despite surpassing Wall Street revenue and profit estimates, the market reacted negatively, reflecting heightened concern over a sharp drop in operating margin and the persis ...

Chevron Corp is one of the biggest energy companies in the world. It drills for oil and natural gas, refines it into usable products like gasoline, and sells it through its gas stations and distribution networks. In recent years, the company has also delved into renewable energy.With that out of the way, let’s start with the leading Dividend Aristocrat:After running the filters, I was left with three companies, so I sorted the list from highest to lowest dividend yield.Number of Analysts: 12 or more. The mo ...

AbbVie Inc. (NYSE:ABBV) is one of the stocks Jim Cramer recently commented on. Cramer highlighted the possible change in spending habits of the rich while discussing the stock, as he said: “AbbVie stock is still falling after management talked about slowing medical aesthetic sales. Botox for the face may have finally hit a wall, even though this business had been booming because so many people didn’t like their slacking faces after they lost so much weight taking the GLP-1s. I found the AbbVie call partic ...

Pharmaceutical stocks are getting more attention these days as the global drug market is expected to reach $1.21 trillion in 2025, showing why the industry matters so much. The growth is driven by new treatments coming out and more people needing specialty medicines. Within this environment, AbbVie (ABBV) delivered third-quarter 2025 results that beat what Wall Street was expecting. The company brought in $15.78 billion in revenue, up 9.1% from the same quarter last year and beating analyst estimates of $ ...